Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
or

Inspyr Therapeutics Inc (NSPX)

Inspyr Therapeutics Inc (NSPX)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
0.0027 -0.0006 (-18.18%) 10/11/21 [OTC US]
N/A x N/A N/A x N/A
Post-market 0.0027 unch (unch) -
Quote Overview for Mon, Oct 11th, 2021
Day Low
0.0026
Day High
0.0034
Open 0.0033
Previous Close 0.0033 0.0033
Volume 29,638,100 29,638,100
Avg Vol 41,076,535 41,076,535
Stochastic %K 34.34% 34.34%
Weighted Alpha -93.43 -93.43
5-Day Change +0.0007 (+35.00%) +0.0007 (+35.00%)
52-Week Range 0.0010 - 0.0718 0.0010 - 0.0718
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure

Fundamentals

See More
  • Market Capitalization, $K 1,467
  • Shares Outstanding, K 543,152
  • Annual Sales, $ 0 K
  • Annual Income, $ -6,300 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta -16.57
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.05
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 11/19/21
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING Medical - Drugs

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0018 +50.00%
on 10/01/21
Period Open: 0.0022
0.0051 -47.06%
on 10/05/21
+0.0005 (+22.73%)
since 09/10/21
3-Month
0.0010 +170.00%
on 08/26/21
Period Open: 0.0066
0.0088 -69.32%
on 08/02/21
-0.0039 (-59.09%)
since 07/09/21
52-Week
0.0010 +170.00%
on 08/26/21
Period Open: 0.0206
0.0718 -96.24%
on 10/13/20
-0.0179 (-86.89%)
since 10/09/20

Most Recent Stories

More News
Inspyr Therapeutics Reports Financial Results and Business Update For Full Year 2020

- Implements new corporate strategy to focus on precision therapeutics for the treatment of cancer - Strengthens pipeline by acquiring a proprietary portfolio of novel adenosine immuno-modulator compounds...

NSPX : 0.0027 (-18.18%)
Inspyr Therapeutics Further Strengthens Global Intellectual Property

WESTLAKE VILLAGE, CA / ACCESSWIRE / February 18, 2021 / Inspyr Therapeutics, Inc. (OTC PINK:NSPX), a pharmaceutical company focused on the research and development of novel targeted precision therapeutics...

NSPX : 0.0027 (-18.18%)

Business Summary

Inspyr Therapeutics, Inc. is a biotechnology company which focuses on the discovery and development of prodrug cancer therapeutics for the treatment of solid tumors, including liver, brain, prostate, and other cancers primarily in the United States. Its product candidates include Mipsagargin, G-115,...

See More

Key Turning Points

3rd Resistance Point 0.0040
2nd Resistance Point 0.0037
1st Resistance Point 0.0032
Last Price 0.0027
1st Support Level 0.0024
2nd Support Level 0.0021
3rd Support Level 0.0016

See More

52-Week High 0.0718
Fibonacci 61.8% 0.0448
Fibonacci 50% 0.0364
Fibonacci 38.2% 0.0280
Last Price 0.0027
52-Week Low 0.0010

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective